作者: J. F Delfraissy
DOI:
关键词: Discontinuation 、 Acquired immunodeficiency syndrome (AIDS) 、 Surgery 、 Immunopathology 、 Medicine 、 Efavirenz 、 Virology 、 Sida 、 Abacavir 、 Lipodystrophy 、 Nevirapine
摘要: 35. 17. MAGGGIOLO F, RIPAMONTI D, GREGIS G et al. Effect of prolonged discontinuation successful antiretroviral therapy on CD4 T cells : a controlled, prospective trial. AIDS, 2004, 18 439-446. 18. RAVASIO L Outcome 2 simplification strategies for the treatment human immunodeficiency virus type 1 infection. Clin Infect Dis, 2003, 37 41-49. 19. MARCUS K, TRUFFA M, BOXWELL D Recently identified adverse events secondary to NRTI in HIV-infected individuals cases from FDA’s reporting system (AERS). 9th CROI, Seattle, 2002, abstract LB14. 20. MARTINEZ E, ARNAIZ JA, PODZAMCKER Substitution nevirapine, efavirenz, or abacavir protease inhibitors patients with N Engl J Med 349 1036-1046. 21. BLANCO JL, JA Hepatotoxicity HIV-1 infected receiving nevirapine-containing therapy. 2001, 15 1261-1268. 22. GARCIA-VIEJO MA, JL Impact switching efavirenz successfully treated adults lipodystrophy. 2000, 31